The Blavatnik Fund for Innovation at Yale bridges the gap between innovative, early-stage life science research and successful development of high-impact biomedical products. Our integrated approach combines essential funding with development and business expertise, leading to commercial partnerships that bring forth new biomedical discoveries that create value and benefit society.
Nov. 1, 2017: Initial Pre-Proposals Due (Apply by this date to receive additional guidance on your application)
Dec. 1, 2017: Final Deadline for Pre-Proposals
Jan. 9, 2018: Final Proposal Selection by Board
March 30, 2018: Final Proposals Due